SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-14-000164
Filing Date
2014-04-21
Accepted
2014-04-21 10:38:26
Documents
7
Period of Report
2014-06-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR APRIL 21, 2014 nymox6kmpm140421.htm 6-K 5336
2 NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR exhibit99-1.htm EX-99.1 137338
3 FORM OF PROXY exhibit99-2.htm EX-99.2 20468
4 exhibit99-1x7x1.jpg GRAPHIC 58733
5 exhibit99-2x1x1.jpg GRAPHIC 12567
6 exhibit99-2x1x2.jpg GRAPHIC 2699
7 exhibit99-2x1x3.jpg GRAPHIC 6625
  Complete submission text file 0001176256-14-000164.txt   275798
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 14773004
SIC: 2835 In Vitro & In Vivo Diagnostic Substances